- Increased pricing of GHG emissions leading to increased operating costs.
- Increased stakeholder concern or negative feedback potentially reducing capital availability and revenue.
- Limited emission data on the supply chain (Scope 3 emissions).
Aspen Pharmacare Holdings Limited
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, Aspen Pharmacare Holdings Limited disclosed greenhouse gas emissions of 149.3K tCO2e/year. By scope: Scope 1: 37.4K tCO2e/year; Scope 2: 111.9K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
149.3K tCO2e/year
2023
Water Usage
1.1K Mℓ/year
2023
Waste
71.0K tons/year
2023
Energy Use
1.1M GJ/year
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 37.4K tCO2e/year |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 111.9K tCO2e/year |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023 | 149.3K tCO2e/year |
| 2022 | 151.3K tCO2e/year |
| 2020-07 to 2021-06 | 187.7K tCO2e/year |
| 2018 | 44.3K tCO2e (Scope 1); 148912 tCO2e (Scope 2) (2018) |
| 2017 | 208.7K tCO2e/year (Scope 1 & 2) |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Reduced Scope 1 emissions from 48,095 tCO2e in 2019 to 37,424 tCO2e in 2023
- Increased waste recycled from 58,821 tonnes in 2020 to 60,976 tonnes in 2023
- Achieved 86% waste recycled as a percentage of waste generated in 2023
🌱 ESG Focus Areas
Access to medicinesHealth securityPatient safetyReliable supply of quality productsResponsible advocacyResponsible marketingResponsible product portfolioDiversity, equity and inclusionEmployee health and safetyEmployee well-beingFair compensationLabour rightsWorkforce developmentComplianceCorporate governanceData governanceEconomic value generated and distributedEthical business cultureFair taxationHuman rightsResponsible supply chain managementSED and investment in communitiesTransformation and economic inclusion (B-BBEE in South Africa)Climate change and greenhouse gas emissionsEnergy efficiencyResource use and wasteWater and effluentBiodiversity and abundanceHealth system strengtheningPharmaceuticals in the environmentProduct environmental stewardshipAnimal welfareClinical trial conduct